You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET medullary thyroid cancer

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

Not yet recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +3 more
  • Chang chun, Jilin, China
    Jinlin Province Cancer Hosipital
Dec 21, 2022

Medullary Thyroid Cancer Trial in Cordoba, Sevilla (Pralsetinib, Cabozantinib, Vandetanib)

Not yet recruiting
  • Medullary Thyroid Cancer
  • Cordoba, Spain
  • +1 more
Jan 11, 2023

Malignant Thyroid Gland Tumor, Poorly Differentiated Thyroid Gland Carcinoma, Recurrent Thyroid Gland Carcinoma Trial in Houston

Recruiting
  • Malignant Thyroid Gland Neoplasm
  • +6 more
  • Quality-of-Life Assessment
  • +3 more
  • Ann Arbor, Michigan
  • +1 more
Jan 24, 2023

Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

Active, not recruiting
Has Results
  • Solid Tumor
  • Medullary Thyroid Cancer
  • Guangzhou, Guangdong, China
  • +12 more
May 9, 2022

NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

Recruiting
  • Non-Small Cell Lung Cancer
  • +2 more
  • Shanghai, Shanghai, China
  • +1 more
Mar 17, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET Gene Mutation Trial in Korea, Republic of, United States (TPX-0046)

Recruiting
  • Non Small Cell Lung Cancer
  • +4 more
  • Irvine, California
  • +15 more
Mar 9, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

Advanced Nonhaematologic Malignancies Trial in Worldwide (BOS172738)

Active, not recruiting
  • Advanced Nonhaematologic Malignancies
  • Philadelphia, Pennsylvania
  • +20 more
Sep 23, 2022

A Detailed Look At What Patients Experience In Medullary Thyroid

Not yet recruiting
  • Medullary Thyroid Cancer
    • San Francisco, California
      Power Life Sciences
    Oct 6, 2023

    Medullary Thyroid Cancer Trial in China (Anlotinib Hydrochloride Capsule)

    Recruiting
    • Medullary Thyroid Cancer
    • Anlotinib Hydrochloride Capsule
    • Hefei, Anhui, China
    • +18 more
    Apr 14, 2023

    Vandetanib in RET -/+ Metastatic Medullary Thyroid Cancer

    Completed
    • Symptomatic, Aggressive, Sporadic, Unresectable, Locally
    • Advanced/Metastatic Medullary Thyroid Cancer (MTC)
    • Vandetanib 300 mg
    • Belgium, Belgium
    • +7 more
    Oct 15, 2020

    Non Small Cell Lung Cancer, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (Selpercatinib)

    Available
    • Non Small Cell Lung Cancer
    • +6 more
    • Goodyear, Arizona
    • +67 more
    Aug 17, 2022

    Familial Non-medullary Thyroid Cancer

    Recruiting
    • Non-Medullary Thyroid Cancer
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Aug 24, 2022

      Children and Adults With Medullary Thyroid Cancer

      Recruiting
      • Medullary Thyroid Cancer
        • Bethesda, Maryland
          National Institutes of Health Clinical Center, 9000 Rockville Pi
        Apr 7, 2022

        Medullary Thyroid Cancer Trial in Worldwide (Selpercatinib, Cabozantinib, Vandetanib)

        Recruiting
        • Medullary Thyroid Cancer
        • Birmingham, Alabama
        • +148 more
        Jan 18, 2023

        Thyroid Cancer, Thyroid Carcinoma, Metastatic Thyroid Cancer Trial in Boston (Selpercatinib, Sodium Iodine I-131, rhTSH)

        Not yet recruiting
        • Thyroid Cancer
        • +5 more
        • Boston, Massachusetts
          Massachusetts General Hospital
        Dec 20, 2022

        Non-Medullary Thyroid Carcinoma Trial (Digoxin tablet)

        Not yet recruiting
        • Non-Medullary Thyroid Carcinoma
        • Digoxin tablet
        • (no location specified)
        Aug 20, 2022

        Medullary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroid Carcinoma, Medullary Trial in Groningen (18F-PSMA-1007)

        Not yet recruiting
        • Medullary Thyroid Cancer
        • +3 more
        • Groningen, Netherlands
          University Medical Centre Groningen
        Sep 8, 2022

        Surgical Management of Advanced Thyroid Cancer

        Recruiting
        • Thyroid Carcinoma
        • +6 more
        • Thyroidectomy with or without lymphadenectomy or multivisceral resection
        • Rome, Italy
          Fondazione Policlinico Universitario Agostino Gemelli IRCCS
        Mar 31, 2023

        Metastatic Sporadic Medullary Thyroid Cancer Patients and

        Completed
        • Metastatic Sporadic Medullary Thyroid Cancer
          • Milano, Italy
            Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
          Sep 29, 2021

          Metastatic Medullary Thyroid Cancer Trial in Philadelphia (single dose of CART-GFRa4 cells, Fludarabine, Cyclophosphamide)

          Recruiting
          • Metastatic Medullary Thyroid Cancer
          • single dose of CART-GFRa4 cells
          • +2 more
          • Philadelphia, Pennsylvania
            University of Pennsylvania
          Sep 16, 2022

          Radioactive Iodine on the Immune System in Thyroid Cancer

          Not yet recruiting
          • Thyroid Carcinoma, Nonmedullary
          • Blood drawing
          • Nijmegen, Netherlands
            Radboud University Medical Center
          Aug 13, 2023

          NSCLC, Thyroid Tumors Trial (LOXO-260)

          Temporarily not available
          • Carcinoma, Non-Small-Cell Lung
          • Thyroid Neoplasms
          • (no location specified)
          Sep 20, 2022

          Medullary Thyroid Cancer Trial (Ponatinib)

          Withdrawn
          • Medullary Thyroid Cancer
          • (no location specified)
          Oct 6, 2021